Getting Into the Specialty Pharmacy Business
October 21-22, 2017
Garden Grove, CA

Get the latest on specialty pharmacy trends in the industry at CPhA's Getting Into the Specialty Pharmacy Business Conference on October 21-22 in Garden Grove.

Target audience includes: pharmacy staff, consultants, managers, directors, and executives from specialty pharmacy providers, infusion pharmacies, pharma/biotech manufacturers, managed care organizations, group purchasing organizations, institutional pharmacies, distributors, and suppliers.   


October 21, 2017 
8:30 am - 9:00 am   Registration & Breakfast
9:00 am - 10:15 am   The Evolution of Specialty Pharmacy
10:30 am - 11:45 am    Developing a Business Plan
11:45 am - 12:45 pm    Lunch & Exhibits Open
12:45 pm - 2:00 pm    Considering Best Practices, Opportunities, Barriers, and Risks
2:15 pm - 3:30 pm    Importance of Managing Adverse Drug Reactions
3:30 pm - 4:45 pm    Contracting Strategies for Specialty Pharmacies
5:00 pm - 7:00 pm   Networking Reception & Exhibits Open
     
October 22, 2017
8:00 am - 9:00 am   Registration & Breakfast
9:00 am - 10:15 am    Leveraging Your Specialty Data to Engage Key Stakeholders
10:30 am - 11:45 am   Understanding the Benefits of Accreditation


October 21, 2017

Click on a session below to learn more:

Presented by: Lisa Betts, National IG Program Director, Walgreens Specialty Infusion

This session will review the progression of specialty pharmacy – why it is the fastest-growing segment of the pharmacy industry. Participants will also review how and why now is the time to enter this thriving area of pharmacy.

Presented by: Vic Simianu, MBA, Principal, Sphinx Strategies, LLC

This session will review how to conduct a successful market analysis so you can assess and choose the disease states to best serve. Additionally, you’ll learn how to develop a business plan that will create the framework for success. Whether you want to build, partner, outsource or manage individual patient risk – you’ll learn the pros and cons for each model.

After successfully completing this session, participants should be able to:
1. List important aspects of market analysis
2. Develop a business plan
3. Review various business models

Presented by: Amy E. Clarke, RN IgCN, Director, Clinical Program Services, Nursing, Diplomat

This session will review best practices in cross-collaborative patient management, address limited distribution challenges and explain the importance of accreditation and certifications. It will also explain the importance of a nurse’s role in specialty infusion space.

After successfully completing this session, participants should be able to:
1. Discuss the benefits of a cross-collaborative approach to patient management
2. Name limited distribution hurdles
3. Recognize the role of nurse in Specialty Infusion space
4. Explain the importance of accreditation and certifications

Presented by: Alan Huber, BS Pharm, PharmD, MBA, President, AIH Specialty Consulting

This session will review the historical perspective of adverse drug reactions and how to successfully manage and report an incident. With an aging population and new medications consistently being FDA approved for commercial use, Specialty Pharmacies will be required to respond accordingly to the FDA, Manufacturers, and Accreditation organization reporting guidelines.

After successfully completing this session, participants should be able to:
1. Define the role of pharmacovigilance.
2. Define what an adverse drug reaction is.
3. Explain how an adverse drug reaction is classified.
4. Outline how to report an adverse drug reaction.

Shivani Patel, Senior Director of Clinical Operations, Asembia

This session will review the various tactics and strategies for contracting with specialty pharmacies. Learn how Group Purchasing Organizations work and understand why closed or restricted specialty pharmacy networks exist and how to enter.

After successfully completing this session, participants should be able to:
1. Identify the types of contracting models
2. Describe the role of Group Purchasing Organizations
3. Explain why manufacturers choose to limit distribution


October 22, 2017

Presented by: Dan Steiber R.Ph. B.Pharm and BS Physical Science, Editor in Chief, Executive Vice President, Specialty Pharmacy Times

This session will review data expectations of specialty pharmacy stakeholders. Attendees will learn how the evolving role of specialty pharmacy providers in an outcomes-based market acquire new strategies to leverage data for value-based reimbursement. The session will also review the fundamental dos and don’ts of contracting strategies and tactics with potential revenue generating relationships.

After successfully completing this session, participants should be able to:
1. Outline the definition of specialty pharmacy and how data within the specialty space is differentiated from standard transactions.
2. Indicate which disease states better lend themselves to data drive opportunities in the marketplace.
3. Recognize who are the key stake holders in a successful specialty pharmacy practice from a data sharing relationship perspective.
4. List Data Service provided by specialty pharmacies to manufacturers, what they are and what they are looking for past, present and future.
5. State the top 5 data metrics in specialty pharmacy reporting

Presented by: Ethan Huynh, VP Pharmacy Operations, CA Specialty Pharmacy

This session will provide an overview of specialty pharmacy accreditation. Define the key components necessary to deliver quality, cost effective pharmacy services and patient management that meet accreditation standards. Dr. Huynh will discuss how to prepare for and what to expect from the accreditation review process. He will also share tips on how to achieve successful accreditation and re-accreditation.

After successfully completing this session, participants should be able to:
1. Identify the steps in the achievement process for accreditation
2. Describe the benefits of accreditation and value proposition to stakeholders
3. Compare the major accreditation organizations and explain key differences among them
4. Define accreditation standards
5. Identify tools and resources available to help achieve and maintain accreditation

 


The California Pharmacists Association (#0113) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Upon completing an evaluation form, participants will be awarded up to 8.75 hours (.875 CEUs) of Continuing Pharmacy Education Credit. A statement of credit will not be issued. Participants may log onto the CPE monitor website using their individual log in to download their statement of credit. Please allow 4 weeks for processing of CPE credits to the CPE monitor.



 


PHARMACISTS
CPhA Member: $399
Non-Member: $549
 
STUDENT PHARMACISTS 
CPhA Member: $229 
Non-Member: $249

Online Registration closes after October 13, 2017. 
Please note: Cancellations are subject to 30% handling fee, there will be NO REFUNDS issued for cancellations received within 10 business days prior to program. Cancellations must be in writing. Refunds will NOT be made for no-shows. However, substitutions will be allowed. Should CPhA cancel the program, a full registration fee refund will be issued.
Hotel Information

Anaheim Marriott Suites
12015 Harbor Blvd.
Garden Grove, CA 92840
Hotel Website

Room rate: $120/night
To make a hotel room reservation, book online by clicking here.

Reservation deadline: September 29, 2017 (or until room block is full)

Parking: Complimentary